182 related articles for article (PubMed ID: 26919145)
1. Clinicopathological significance of caspase-3 and Ki-67 expression in canine mammary gland tumours.
Rodrigues H; Carvalho MI; Pires I; Prada J; Queiroga FL
Acta Vet Hung; 2016 Mar; 64(1):78-89. PubMed ID: 26919145
[TBL] [Abstract][Full Text] [Related]
2. Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis.
Carvalho MI; Pires I; Prada J; Lobo L; Queiroga FL
Vet Pathol; 2016 Nov; 53(6):1138-1146. PubMed ID: 27162119
[TBL] [Abstract][Full Text] [Related]
3. Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours.
Yang WY; Liu CH; Chang CJ; Lee CC; Chang KJ; Lin CT
J Comp Pathol; 2006 Jan; 134(1):70-9. PubMed ID: 16423573
[TBL] [Abstract][Full Text] [Related]
4. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical identification method of tumour cells in the S phase of mitotic cycle and its usefulness in diagnostics of mammary gland adenocarcinomas in bitches.
Nowak M; Madej JA; Dziegiel P; Kanzawa H
Pol J Vet Sci; 2006; 9(1):57-62. PubMed ID: 16573276
[TBL] [Abstract][Full Text] [Related]
6. Detection of neurokinin-1 receptor by immunohistochemistry in canine mammary gland tumours.
Song D; Oh YI; Kim JM; Cheon DS; Kim DY; Seo KW
Vet Med Sci; 2020 Nov; 6(4):958-964. PubMed ID: 32657032
[TBL] [Abstract][Full Text] [Related]
7. MIB-1 labelling indices according to clinico-pathological variables in canine mammary tumours: a multivariate study.
De Matos AJ; Lopes CC; Faustino AM; Carvalheira JG; Dos Santos MS; Rutteman GR; Gärtner Mde F
Anticancer Res; 2006; 26(3A):1821-6. PubMed ID: 16827113
[TBL] [Abstract][Full Text] [Related]
8. Expression and prognostic value of c-met in canine mammary tumours.
Chen YC; Chen YY; Liao JW; Chang SC
Vet Comp Oncol; 2018 Dec; 16(4):670-676. PubMed ID: 30129270
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of progesterone and cellular proliferation in canine mammary tumours.
Thuróczy J; Reisvaag GJ; Perge E; Tibold A; Szilágyi J; Balogh L
J Comp Pathol; 2007; 137(2-3):122-9. PubMed ID: 17645888
[TBL] [Abstract][Full Text] [Related]
10. Down-expression of klotho in canine mammary gland tumors and its prognostic significance.
Chung H; Lee S; Kim GA; Kim WH
PLoS One; 2022; 17(6):e0265248. PubMed ID: 35666743
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D receptor expression in canine mammary gland and relationship with clinicopathological parameters and progesterone/oestrogen receptors.
Sánchez-Céspedes R; Fernández-Martínez MD; Raya A; Pineda C; López I; Millán Y
Vet Comp Oncol; 2018 Mar; 16(1):E185-E193. PubMed ID: 29178579
[TBL] [Abstract][Full Text] [Related]
12. High COX-2 expression is associated with increased angiogenesis, proliferation and tumoural inflammatory infiltrate in canine malignant mammary tumours: a multivariate survival study.
Carvalho MI; Pires I; Prada J; Raposo TP; Gregório H; Lobo L; Queiroga FL
Vet Comp Oncol; 2017 Jun; 15(2):619-631. PubMed ID: 26792550
[TBL] [Abstract][Full Text] [Related]
13. Expression of extracellular matrix metalloproteinase (MMP-9), E-cadherin and proliferation-associated antigen Ki-67 and their reciprocal correlation in canine mammary adenocarcinomas.
Nowak M; Madej JA; Podhorska-Okolow M; Dziegiel P
In Vivo; 2008; 22(4):463-9. PubMed ID: 18712173
[TBL] [Abstract][Full Text] [Related]
14. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
Gama A; Alves A; Schmitt F
Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
[TBL] [Abstract][Full Text] [Related]
15. Expression and significance of PTEN in canine mammary gland tumours.
Qiu C; Lin D; Wang J; Wang L
Res Vet Sci; 2008 Oct; 85(2):383-8. PubMed ID: 18082231
[TBL] [Abstract][Full Text] [Related]
16. Validation of the use of proliferation markers in canine neoplastic and non-neoplastic tissues: comparison of KI-67 and proliferating cell nuclear antigen (PCNA) expression versus in vivo bromodeoxyuridine labelling by immunohistochemistry.
Zacchetti A; van Garderen E; Teske E; Nederbragt H; Dierendonck JH; Rutteman GR
APMIS; 2003 Mar; 111(3):430-8. PubMed ID: 12752223
[TBL] [Abstract][Full Text] [Related]
17. Decorin concentrations in canine normal and neoplastic mammary gland tissues.
Szczubiał M; Kankofer M; Wawrzykowski J; Dąbrowski R; Łopuszyński W; Bochniarz M; Brodzki P
Reprod Domest Anim; 2020 Oct; 55(10):1404-1410. PubMed ID: 33470009
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues.
Gama A; Gärtner F; Alves A; Schmitt F
Res Vet Sci; 2009 Dec; 87(3):432-7. PubMed ID: 19464036
[TBL] [Abstract][Full Text] [Related]
19. Expression of iNOS, COX-2 and VEGF in canine mammary tumours and non-neoplastic mammary glands: Association with clinicopathological features and tumour grade.
Anadol E; Yar Saglam AS; Gultiken N; Karakas K; Alcigir E; Alkan H; Kanca H
Acta Vet Hung; 2017 Sep; 65(3):382-393. PubMed ID: 28956485
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of IGF-I and IGF-II expression in canine mammary tumours: Prognostic and diagnostic role.
Ozmen O
Acta Vet Hung; 2020 Sep; 68(3):269-274. PubMed ID: 33221734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
